Immune thrombocytopenic purpura induced by the COVID-19 vaccine after the second dose in a 78-year-old patient: A case report

Coronavirus disease 2019 (COVID-19) has become a global pandemic, but treatment options remain limited. Up to now, vaccination has been the main strategy to prevent transmission and reduce disease severity. However, with follow-up observations after massive vaccination, immune thrombocytopenic purpu...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wenhui, Wu, Tao, Xue, Feng, Tian, Hongjuan, Song, Rui, Bai, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353547/
https://www.ncbi.nlm.nih.gov/pubmed/35949340
http://dx.doi.org/10.3892/etm.2022.11517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353547/
https://www.ncbi.nlm.nih.gov/pubmed/35949340
http://dx.doi.org/10.3892/etm.2022.11517

Ejemplares similares